Joanna E Frackowiak
Overview
Explore the profile of Joanna E Frackowiak including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
10
Citations
53
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Frackowiak J, Kubica P, Kosno M, Potega A, Owczarek-Grzymkowska K, Borzyszkowska-Bukowska J, et al.
J Pharm Biomed Anal
. 2024 Oct;
252:116493.
PMID: 39368137
Unsymmetrical bisacridines (UAs) represent a novel class of anticancer agents. Their high cytotoxicity towards multiple human cancer cell lines and inhibition of human tumor xenograft growth in nude mice signal...
2.
Kobiela A, Hewelt-Belka W, Frackowiak J, Kordulewska N, Hovhannisyan L, Bogucka A, et al.
Front Immunol
. 2024 Apr;
15:1369238.
PMID: 38585273
Introduction: Exosome-enriched small extracellular vesicles (sEVs) are nanosized organelles known to participate in long distance communication between cells, including in the skin. Atopic dermatitis (AD) is a chronic inflammatory skin...
3.
Laskowski T, Kosno M, Andralojc W, Frackowiak J, Borzyszkowska-Bukowska J, Szczeblewski P, et al.
Sci Rep
. 2023 Mar;
13(1):3431.
PMID: 36859494
Members of a novel class of anticancer compounds, exhibiting high antitumor activity, i.e. the unsymmetrical bisacridines (UAs), consist of two heteroaromatic ring systems. One of the ring systems is an...
4.
Kosno M, Laskowski T, Frackowiak J, Potega A, Kurdyn A, Andralojc W, et al.
Molecules
. 2022 Jul;
27(13).
PMID: 35807234
Unsymmetrical bisacridines (UAs) represent a novel class of anticancer agents previously synthesized by our group. Our recent studies have demonstrated their high antitumor potential against multiple cancer cell lines and...
5.
Kobiela A, Frackowiak J, Biernacka A, Hovhannisyan L, Bogucka A, Panek K, et al.
Front Immunol
. 2022 Jul;
13:884530.
PMID: 35784319
infection is a potential complication in the individuals with atopic dermatitis (AD) and can affect clinical course of the disease. Here, using primary keratinocytes we determined that atopic promotes changes...
6.
Krychowiak-Masnicka M, Krauze-Baranowska M, Godlewska S, Kaczynski Z, Bielicka-Gieldon A, Grzegorczyk N, et al.
Int J Mol Sci
. 2021 Jun;
22(9).
PMID: 34063704
Carnivorous plants are exemplary natural sources of secondary metabolites with biological activity. However, the therapeutic antimicrobial potential of these compounds is limited due to intrinsic resistance of selected bacterial pathogens,...
7.
Mikosik A, Jasiulewicz A, Daca A, Henc I, Frackowiak J, Ruckemann-Dziurdzinska K, et al.
Oncotarget
. 2016 Nov;
7(47):76479-76495.
PMID: 27835610
The immune response is determined by the speed of the T cell reaction to antigens assured by a state of readiness for proliferation and cytokine secretion. Proliferation, apoptosis and motion...
8.
Banasiuk R, Frackowiak J, Krychowiak M, Matuszewska M, Kawiak A, Ziabka M, et al.
Int J Nanomedicine
. 2016 Feb;
11:315-24.
PMID: 26855570
A fast, economical, and reproducible method for nanoparticle synthesis has been developed in our laboratory. The reaction is performed in an aqueous environment and utilizes light emitted by commercially available...
9.
Mikosik A, Henc I, Ruckemann-Dziurdzinska K, Frackowiak J, Ploszynska A, Balcerska A, et al.
PLoS One
. 2015 Aug;
10(8):e0136615.
PMID: 26317226
Childhood acute lymphoblastic leukemia (ALL) blasts are characterized by inhibited apoptosis promoting fast disease progress. It is known that in chronic lymphocytic and acute myeloid leukemias the reduced apoptosis is...
10.
Lisowska K, Frackowiak J, Mikosik A, Witkowski J
PLoS One
. 2013 Apr;
8(4):e60326.
PMID: 23577103
We have recently described the presence of the erythropoietin receptor (EPO-R) on CD4(+) lymphocytes and demonstrated that its expression increases during their activation, reaching a level reported to be typical...